Emblaze wins Vodafone contract

The deal comes one month after Emblaze Mobile won a $100 million tender from UK-based Virgin Mobile to design handsets for its Lobster phone range.

By AVI KRAWITZ
July 5, 2006 08:09
emblaze logo 88

emblaze logo 88. (photo credit: )

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Emblaze Mobile has won a "significant" contract with one of Britain's largest cellular providers - Vodafone - to promote and distribute a range of products under the operator's "Pay As You Talk" offering. The handset manufacturing unit of Ra'anana-based Emblaze Group said Tuesday it was selected by Vodafone to broaden sales of "Pay as you talk" handsets and services across the dealer and retail community in the UK. Vodafone has approximately 16.5 million pay as you talk customers. The deal comes one month after Emblaze Mobile won a $100 million tender from UK-based Virgin Mobile to design handsets for its Lobster phone range.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS